Please see below for a list of search results.
The HTA was asked to provide a copy of our policy on managing and referring potential criminal breaches of Human Tissue Legislation.
The HTA was asked to provide information on the structure, number of staff, and procurement process of the HTA's finance department.
We were asked to provide information on HTA Reportable Incidents in the post-mortem sector between 2018 and 2019.
The HTA was asked to provide information on the number of lost and stolen laptops, mobile phones and tablet computers by HTA employees over the past three financial years.
We were asked to provide original documentation submitted as part of King's Health Partners Cancer Biobank's application for an HTA licence.
The HTA was asked to provide information on whether the company ‘Celixir’ had an HTA licence from 2010-13, for importing blood from patients at the Morriston Hospital and deriving mesenchymal stromal cells for research purposes.
HTA was asked to provide information on its workforce expenses between April and May 2019.
The HTA was asked to provide information on the number of umbilical cord blood tissue and dental pulp units processed in the UK from 2014 - 2018. This was requested alongside the number of UK organisations that the HTA took regulatory action against.
The HTA was asked to provide documentation - including letters, emails, reports, and meeting minutes - related to concens about the Wellcome Sanger Institute's compliance with the Human Tissue Act in 2019.
The HTA was asked to provide information on the Serious Adverse Events and Reactions in the organ donation and transplantation sector.